309
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Prediction of Optimal Warfarin Maintenance Dose Using Advanced Artificial Neural Networks

, , , , , , , & show all
Pages 29-37 | Published online: 16 Dec 2013

References

  • Ansell JE . 9th National conference on anticoagulant therapy preface. J. Thromb. Thrombolysis25(1) , 1 (2008).
  • Hirsh J , FusterV, AnsellJ, HalperinJL, AHAACOC Foundation. American Heart Association/American College of Cardiology foundation guide to warfarin therapy. J. Am. Coll. Cardiol.41(9) , 1633–1652 (2003).
  • Loebstein R , YonathH, PelegD et al. Interindividual variability in sensitivity to warfarin–nature or nurture? Clin. Pharmacol. Ther. 70(2) , 159–164 (2001).
  • Lubitz SA , ScottSA, RothlaufEB et al. Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population. J. Thromb. Haemost. 8(5) , 1018–1026 (2010).
  • Takahashi H , EchizenH. Pharmacogenetics of warfarin elimination and its clinical implications. Clin. Pharmacokinet.40(8) , 587–603 (2001).
  • Margaglione M , ColaizzoD, D‘AndreaG et al. Genetic modulation of oral anticoagulation with warfarin. Thromb. Haemost. 84(5) , 775–778 (2000).
  • Sanderson S , EmeryJ, HigginsJ. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet. Med.7(2) , 97–104 (2005).
  • Scordo MG , AklilluE, YasarU, DahlML, SpinaE, Ingelman-SundbergM. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population. Br. J. Clin. Pharmacol.52(4) , 447–450 (2001).
  • Sipeky C , LaknerL, SzaboM et al. Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies. Blood Cells Mol. Dis. 43(3) , 239–242 (2009).
  • Spreafico M , LodigianiC, van Leeuwen Y et al. Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy. Pharmacogenomics9(9) , 1237–1250 (2008).
  • Jorgensen AL , FitzgeraldRJ, OyeeJ, PirmohamedM, WilliamsonPR. Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis. PLoS ONE7(8) , e44064 (2012).
  • McClain MR , PalomakiGE, PiperM, HaddowJE. A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding. Genet. Med.10(2) , 89–98 (2008).
  • Wadelius M , ChenLY, LindhJD et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 113(4) , 784–792 (2009).
  • Geisen C , WatzkaM, SittingerK et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb. Haemost.94(4) , 773–779 (2005).
  • Wysowski DK , NourjahP, SwartzL. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch. Intern. Med.167(13) , 1414–1419 (2007).
  • Budnitz DS , ShehabN, KeglerSR, RichardsCL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann. Intern. Med.147(11) , 755–765 (2007).
  • Cross SS , HarrisonRF, KennedyRL. Introduction to neural networks. Lancet346(8982) , 1075–1079 (1995).
  • Dayhoff JE , DeleoJM. Artificial neural networks: opening the black box. Cancer91(8 Suppl.) , S1615–S1635 (2001).
  • Tabaton M , OdettiP, CammarataS et al. Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment. J. Alzheimers Dis. 19(3) , 1035–1040 (2010).
  • Ansari D , NilssonJ, AnderssonR, RegnerS, TingstedtB, AnderssonB. Artificial neural networks predict survival from pancreatic cancer after radical surgery. Am. J. Surg.205(1) , 1–7 (2013).
  • Rughani AI , DumontTM, LuZ et al. Use of an artificial neural network to predict head injury outcome. J. Neurosurg. 113(3) , 585–590 (2010).
  • Manotti C , MoiaM, PalaretiG, PengoV, RiaL, DettoriAG. Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (automated program for oral anticoagulant treatment). Haematologica86(10) , 1060–1070 (2001).
  • Ageno W , TurpieAG. A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy. Thromb. Res.91(5) , 237–240 (1998).
  • Poller L . International normalized ratios (INR): the first 20 years. J. Thromb. Haemost.2(6) , 849–860 (2004).
  • Greenland S , SchwartzbaumJA, FinkleWD. Problems due to small samples and sparse data in conditional logistic regression analysis. Am. J. Epidemiol.151(5) , 531–539 (2000).
  • Penco S , BuscemaM, PatrossoMC, MarocchiA, GrossiE. New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. BMC Bioinformatics9 , 254 (2008).
  • Buscema M , GrossiE, IntraligiM, GarbagnaN, AndriulliA, BredaM. An optimized experimental protocol based on neuro-evolutionary algorithms application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment. Artif. Intell. Med.34(3) , 279–305 (2005).
  • Buscema M , GrossiE, SnowdonD et al. Artificial neural networks and artificial organisms can predict Alzheimer pathology in individual patients only on the basis of cognitive and functional status. Neuroinformatics 2(4) , 399–416 (2004).
  • Haykin S . Neural networks: a Comprehensive Foundation. Prentice Hall PTR, NJ, USA (1998).
  • Gong IY , TironaRG, SchwarzUI et al. Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood 118(11) , 3163–3171 (2011).
  • International Warfarin Pharmacogenetics Consortium, Klein TE, Altman RB et al. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med.360(8) , 753–764 (2009).
  • Lenzini P , WadeliusM, KimmelS et al. Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin. Pharmacol. Ther. 87(5) , 572–578 (2010).
  • Millican EA , LenziniPA, MilliganPE et al. Genetic-based dosing in orthopedic patients beginning warfarin therapy. Blood 110(5) , 1511–1515 (2007).
  • Sconce EA , KhanTI, WynneHA et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood 106(7) , 2329–2333 (2005).
  • Voora D , EbyC, LinderMW et al. Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype. Thromb. Haemost. 93(4) , 700–705 (2005).
  • Caraco Y , BlotnickS, MuszkatM. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Clin. Pharmacol. Ther.83(3) , 460–470 (2008).
  • Anderson JL , HorneBD, StevensSM et al. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. Circulation 116(22) , 2563–2570 (2007).
  • Zambon CF , PengoV, PadriniR et al. VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. Pharmacogenomics12(1) , 15–25 (2011).
  • Gage BF , EbyC, JohnsonJA et al. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin. Pharmacol. Ther. 84(3) , 326–331 (2008).
  • Moreno L , PiñeiroJD, SánchezJL et al. Brain maturation estimation using neural classifier. IEEE Trans. Biomed. Eng. 42(4) , 428–432 (1995).
  • Buscema M . Artificial neural networks and complex social systems. I. theory. Subst. Use Misuse33(1) , v–xvii, 1–220 (1998).
  • Rumelhart DE , McClellandJL. Parallel Distributed Processing. Explorations in the Microstructure of Cognition: Foundations. MIT Press, MA, USA, 1 (1986).
  • Bridle JS . Probabilistic interpretation of feedforward classification network outputs, with relationships to statistical pattern recognition. In: Neuro-Computing: Algorithms, Architectures. NATO ASI Series F68. Fogelman-Soulié F, Hérault J (Eds). Springer-Verlag, NY, USA (1989).
  • Buscema M , SaccoPL. Feedforward networks in financial predictions: the future that modifies the present. Expert Syst.17(3) , 149–170 (2000).
  • Eikelboom JW , ConnollySJ, BrueckmannM et al. Dabigatran versus warfarin in patients with mechanical heart valves. N. Engl. J. Med. 369(13) , 1206–1214 (2013).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.